Third Phase 3 Trial of Sativex, Cannabis Extract for MS Spasticity, Planned episode artwork

EPISODE · Sep 17, 2021 · 10 MIN

Third Phase 3 Trial of Sativex, Cannabis Extract for MS Spasticity, Planned

from MS News & Perspectives · host MS News Today

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a phase 3 trial of Sativex, a cannabis extract, for MS spasticity.Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “MS Paralympian Aims for a Bull’s-eye”.===================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/ =====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/

Episode metadata supplied by the publisher feed · Published Sep 17, 2021

Embed this episode

NOW PLAYING

Third Phase 3 Trial of Sativex, Cannabis Extract for MS Spasticity, Planned

0:00 10:52

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MS News & Perspectives?

This episode is 10 minutes long.

When was this MS News & Perspectives episode published?

This episode was published on September 17, 2021.

Can I download this MS News & Perspectives episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!